The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure

Blood

Volumn 115, Issue 3, 2010, Pages 541-548

  Tang, Yong ^a   Desierto, Marie J ^a   Chen, Jichun ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DEPRESSION; BONE MARROW HYPOPLASIA; CELL COMPOSITION; CELL EXPANSION; CONTROLLED STUDY; FEMALE; GENE DELETION; HISTOCOMPATIBILITY COMPLEX; IMMUNE RESPONSE; LYMPH NODE CELL; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PANCYTOPENIA; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; BLOOD CELL COUNT; BONE MARROW DISEASE; C57BL MOUSE; DISEASE MODEL; GENETICS; HEMATOPOIESIS; IMMUNOLOGY; IMMUNOPATHOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BLOOD CELL COUNT; BONE MARROW DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HEMATOPOIESIS; IMMUNE SYSTEM DISEASES; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-BOX DOMAIN PROTEINS; TH1 CELLS;

EID: 77449092131     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-211383     Document Type: Article

References (37)

1. Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15(3):162-168.
2. Kojima S, Frickhofen N, Deeg HJ, et al. Aplastic anemia. Int J Hematol. 2005;82(5):408-411.
3. Nagy SM Jr, Fisher JJ. Aplastic anemia and immunosuppression [abstract]. JAMA. 2003;290(2):193.
4. Abdelkefi A, Ben OT, Ladeb S, et al. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center. Hematol J. 2003;4(3):208-213.
5. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol. 1994;22(11):1102-1110.
6. Békássy AN, Locasciulli A, Marsh JC, et al. Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling. Pediatr Blood Cancer. 2005;45(3):359-360.
7. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000;96(6):2049-2054.
8. Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol. 2000;37(1):56-68.
9. Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and cyclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol. 2006;133(6):622-627.
10. Marsh JC. Results of immunosuppression in aplastic anaemia. Acta Haematol. 2000;103(1):26-32.
11. Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS. Intracellular interferongamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood. 2002;100(4):1185-1191.
12. Solomou EE, Keyvanfar K, Young NS. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood. 2006;107(10):3983-3991.
13. Szabo SJ, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science. 2002;295(5553):338-342.
14. Finotto S, Neurath MF, Glickman JN, et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 2002;295(5553):336-338.
15. Bloom ML, Wolk AG, Simon-Stoos KL, Bard JS, Chen J, Young NS. A mouse model of lymphocyte infusion-induced bone marrow failure. Exp Hematol. 2004;32(12):1163-1172.
16. Chen J, Lipovsky K, Ellison FM, Calado RT, Young NS. Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure. Blood. 2004;104(6):1671-1678.
17. Chen J, Ellison FM, Eckhaus MA, et al. Minor antigen H60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells. J Immunol. 2007;178(7):4159-4168.
18. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995;85(11):3183-3190.
19. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273(5272):242-245.
20. Zhao Y, Zhan Y, Lin Y, et al. Regulation of murine hematopoietic stem cell proliferation in vivo. Blood. 2000;96(9):3016-3022.
21. Yang L, Dybedal I, Bryder D, et al. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol. 2005;174(2):752-757.
22. Zoumbos NC, Gascon P, Djeu JY, Young NS. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A. 1985;82(1):188-192.
23. Killick SB, Cox CV, Marsh JCW, Gordon-Smith EC, Gibson FM. Mechanisms of bone marrow progenitor cell apoptosis in aplastic anemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol. 2000;111(4):1164-1169.
24. Li W, Fu J, Wang F, Yu G, Wang Y, Zhang X. Distinct overexpression of Fas Ligand on T lymphocytes in aplastic anemia. Cell Mol Immunol. 2004;1(2):142-147.
25. Omokaro SO, Desierto MJ, Eckhaus MA, et al. Lymphocytes with aberrant expression of Fas or Fasligand attenuate immune bone marrow failure in a mouse model. J Immunol. 2009;182(6):3414-3422.
26. Sarcon AK, Desierto MJ, Zhou W, et al. The role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure. Exp Hematol. 2009;37(4):477-486.
27. Garrett WS, Lord GM, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131(1):33-45.
28. Juedes AE, Rodrigo E, Togher L, Glimcher LH, von Herrath MG. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J Exp Med. 2004;199(8):1153-1162.
29. + cells of patients with aplastic anaemia. Br J Haematol. 1995;91(1):245-252.
30. Peng SL, Townsend MJ, Hecht JL, White IA, Glimcher LH. T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res. 2004;64(2):452-455.
31. Phoon RK, Kitching AR, Odobasic D, et al. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2008;19(3):477-485.
32. Werneck MB, Lugo-Villarino G, Hwang ES, Cantor H, Glimcher LH. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J Immunol. 2008;180(12):8004-8010.
33. Bettelli E, Sullivan B, Szabo SJ, et al. Loss of Tbet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med. 2004;200(1):79-87.
34. Fujiwara M, Hirose K, Kagami S, et al. T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J Allergy Clin Immunol. 2007;119(3):662-670.
35. Gocke AR, Cravens PD, Ben LH, et al. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J Immunol. 2007;178(3):1341-1348.
36. Santarlasci V, Maggi L, Capone M, et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol. 2009;39(1):207-215.
37. Yang Y, Xu J, Niu Y, Bromberg JS, Ding Y. T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J Immunol. 2008;181(12):8700-8710.